Price (90d)
$169.90Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.20B | $329.86M | $3.60 |
| 2024 | $2.70B | $281.94M | $3.08 |
| 2023 | $2.50B | $245.85M | $2.68 |
| 2022 | $2.23B | $238.19M | $2.60 |
| 2021 | $2.12B | $305.87M | $3.24 |
Social Signal Score
Earnings
Mon, Nov 2(in 3 months)
Consensus estimate $1.21 per share
Typical surprise +19.0% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 3$1.07 vs $1.04beat
- Mon, May 4$1.12 vs $0.92beat
- Mon, Feb 23$1.08 vs $0.89beat
- Mon, Nov 3$1.00 vs $0.85beat
- Mon, Aug 4$1.02 vs $0.79beat
- Mon, May 5$0.91 vs $0.77beat
Estimates and results for BWXT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from BWXT's reported EPS growth of 2.7% a year over 4 years.
- EPS in 5 years
- $4.12
- Implied price
- $197.56
- Return from $173.22
- 2.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $98.22 — -43.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 34 | 41 | 48 | 55 | 62 |
|---|---|---|---|---|---|
| -7.3% | -13.5% | -10.2% | -7.3% | -4.8% | -2.5% |
| -2.3% | -8.8% | -5.4% | -2.3% | 0.4% | 2.8% |
| 2.7% | -4.2% | -0.5% | 2.7% | 5.5% | 8.1% |
| 7.7% | 0.5% | 4.3% | 7.7% | 10.6% | 13.3% |
| 12.7% | 5.2% | 9.2% | 12.7% | 15.8% | 18.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (3)
- Newszacks.com·2d ago·Neutral
Can BWX Technologies' Nuclear Medicine Expansion Boost Growth? BWXT expands its commercial nuclear portfolio through nuclear medicine, isotope production and radiopharmaceutical capabilities.
View source ↗ - Newsseekingalpha.com·4d ago·Positive
BWX Technologies: Fundamentals Are Good But Valuation Is Expensive BWX Technologies (BWXT) earns a hold rating due to strong fundamentals but limited upside at current valuation. Naval business provides multi-year revenue visibility, supported by a $6.93 billion Government Operations backlog. Commercial Operations offers growth potential, with 39% organic revenue growth in Q1 2026 and margin expansion opportunities.
View source ↗ - Newsfool.com·7d ago·Positive
Advance Auto Parts vs. BWX Technologies: Is an Auto Parts Retailer or a Nuclear Energy Pioneer the Better Buy in 2026? Advance Auto Parts is executing a major restructuring plan to streamline its supply chain and enhance store efficiency. BWX Technologies maintains a dominant position in the nuclear propulsion market with a massive revenue backlog from government contracts.
View source ↗